Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 219

1.

Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies.

Monagle P, Lensing AWA, Thelen K, Martinelli I, Male C, Santamaría A, Samochatova E, Kumar R, Holzhauer S, Saracco P, Simioni P, Robertson J, Grangl G, Halton J, Connor P, Young G, Molinari AC, Nowak-Göttl U, Kenet G, Kapsa S, Willmann S, Pap AF, Becka M, Twomey T, Beyer-Westendorf J, Prins MH, Kubitza D; EINSTEIN-Jr Phase 2 Investigators.

Lancet Haematol. 2019 Aug 13. pii: S2352-3026(19)30161-9. doi: 10.1016/S2352-3026(19)30161-9. [Epub ahead of print]

PMID:
31420317
2.

The BACH1-HMOX1 Regulatory Axis Is Indispensable for Proper Macrophage Subtype Specification and Skeletal Muscle Regeneration.

Patsalos A, Tzerpos P, Halasz L, Nagy G, Pap A, Giannakis N, Lyroni K, Koliaraki V, Pintye E, Dezso B, Kollias G, Spilianakis CG, Nagy L.

J Immunol. 2019 Aug 12. pii: ji1900553. doi: 10.4049/jimmunol.1900553. [Epub ahead of print]

PMID:
31405954
3.

Analysis of microRNA expression in brush cytology specimens improves the diagnosis of pancreatobiliary cancer.

Le N, Fillinger J, Szanyi S, Wichmann B, Nagy ZB, Ivády G, Burai M, Tarpay Á, Pozsár J, Pap Á, Molnár B, Csuka O, Bak M, Tulassay Z, Szmola R.

Pancreatology. 2019 Apr 2. pii: S1424-3903(19)30088-2. doi: 10.1016/j.pan.2019.04.001. [Epub ahead of print]

PMID:
31400934
4.

"Beige" Cross Talk Between the Immune System and Metabolism.

Banfai K, Ernszt D, Pap A, Bai P, Garai K, Belharazem D, Pongracz JE, Kvell K.

Front Endocrinol (Lausanne). 2019 Jun 18;10:369. doi: 10.3389/fendo.2019.00369. eCollection 2019.

5.

Effect of Neladenoson Bialanate on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.

Shah SJ, Voors AA, McMurray JJV, Kitzman DW, Viethen T, Bomfim Wirtz A, Huang E, Pap AF, Solomon SD.

JAMA. 2019 Jun 4;321(21):2101-2112. doi: 10.1001/jama.2019.6717.

PMID:
31162568
6.

Sublingual immunotherapy alters salivary IgA and systemic immune mediators in timothy allergic children.

Huoman J, Papapavlou G, Pap A, Alm J, Nilsson LJ, Jenmalm MC.

Pediatr Allergy Immunol. 2019 Aug;30(5):522-530. doi: 10.1111/pai.13047. Epub 2019 Apr 14.

PMID:
30803044
7.

Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III study.

Lensing AWA, Male C, Young G, Kubitza D, Kenet G, Patricia Massicotte M, Chan A, Molinari AC, Nowak-Goettl U, Pap ÁF, Adalbo I, Smith WT, Mason A, Thelen K, Berkowitz SD, Crowther M, Schmidt S, Price V, Prins MH, Monagle P.

Thromb J. 2018 Dec 21;16:34. doi: 10.1186/s12959-018-0188-y. eCollection 2018.

8.

Extended Sialylated O-Glycan Repertoire of Human Urinary Glycoproteins Discovered and Characterized Using Electron-Transfer/Higher-Energy Collision Dissociation.

Darula Z, Pap Á, Medzihradszky KF.

J Proteome Res. 2019 Jan 4;18(1):280-291. doi: 10.1021/acs.jproteome.8b00587. Epub 2018 Nov 19.

PMID:
30407017
9.

Assessing the reproducibility of an O-glycopeptide enrichment method with a novel software, Pinnacle.

Pap A, Prakash A, F Medzihradszky K, Darula Z.

Electrophoresis. 2018 Dec;39(24):3142-3147. doi: 10.1002/elps.201800223. Epub 2018 Aug 30.

PMID:
30117533
10.

Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin.

Prandoni P, Lensing AWA, Prins MH, Gebel M, Pap AF, Homering M, Bauersachs R, Beyer-Westendorf J, Bounameaux H, Cohen AT, Davidson BL, van Bellen B, Verhamme P, Wells PS, Yuan Z, Levitan B, Weitz JI.

Thromb Res. 2018 Aug;168:121-129. doi: 10.1016/j.thromres.2018.06.009. Epub 2018 Jul 10.

PMID:
30064683
11.

Arginine Methyltransferase PRMT8 Provides Cellular Stress Tolerance in Aging Motoneurons.

Simandi Z, Pajer K, Karolyi K, Sieler T, Jiang LL, Kolostyak Z, Sari Z, Fekecs Z, Pap A, Patsalos A, Contreras GA, Reho B, Papp Z, Guo X, Horvath A, Kiss G, Keresztessy Z, Vámosi G, Hickman J, Xu H, Dormann D, Hortobagyi T, Antal M, Nógrádi A, Nagy L.

J Neurosci. 2018 Aug 29;38(35):7683-7700. doi: 10.1523/JNEUROSCI.3389-17.2018. Epub 2018 Jul 27.

12.

New near-infrared rhodamine dyes with large Stokes shifts for sensitive sensing of intracellular pH changes and fluctuations.

Zhang Y, Xia S, Fang M, Mazi W, Zeng Y, Johnston T, Pap A, Luck RL, Liu H.

Chem Commun (Camb). 2018 Jul 5;54(55):7625-7628. doi: 10.1039/c8cc03520b.

13.

Consumption of conjugated linoleic acid (CLA)-supplemented diet during colitis development ameliorates gut inflammation without causing steatosis in mice.

Moreira TG, Gomes-Santos AC, Horta LS, Goncalves MC, Santiago AF, Lauar JG, Dos Reis DS, Castro-Junior AB, Lemos L, Guimarães M, Aguilar EC, Pap A, Amaral JF, Alvarez-Leite JI, Cara DC, Rezende RM, Nagy L, Faria AMC, Maioli TU.

J Nutr Biochem. 2018 Jul;57:238-245. doi: 10.1016/j.jnutbio.2018.04.003. Epub 2018 Apr 27.

PMID:
29800810
14.

Status Report on the High-Throughput Characterization of Complex Intact O-Glycopeptide Mixtures.

Pap A, Klement E, Hunyadi-Gulyas E, Darula Z, Medzihradszky KF.

J Am Soc Mass Spectrom. 2018 Jun;29(6):1210-1220. doi: 10.1007/s13361-018-1945-7. Epub 2018 May 5.

PMID:
29730764
15.

Risk of recurrent venous thromboembolism according to baseline risk factor profiles.

Prins MH, Lensing AWA, Prandoni P, Wells PS, Verhamme P, Beyer-Westendorf J, Bauersachs R, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Kakkar AK, van Bellen B, Pap AF, Homering M, Tamm M, Weitz JI.

Blood Adv. 2018 Apr 10;2(7):788-796. doi: 10.1182/bloodadvances.2018017160.

16.

Liver X Receptor Nuclear Receptors Are Transcriptional Regulators of Dendritic Cell Chemotaxis.

Beceiro S, Pap A, Czimmerer Z, Sallam T, Guillén JA, Gallardo G, Hong C, A-Gonzalez N, Tabraue C, Diaz M, Lopez F, Matalonga J, Valledor AF, Dominguez P, Ardavin C, Delgado-Martin C, Partida-Sanchez S, Rodriguez-Fernandez JL, Nagy L, Tontonoz P, Castrillo A.

Mol Cell Biol. 2018 Apr 30;38(10). pii: e00534-17. doi: 10.1128/MCB.00534-17. Print 2018 May 15.

17.

PPARgamma Deficiency Counteracts Thymic Senescence.

Ernszt D, Banfai K, Kellermayer Z, Pap A, Lord JM, Pongracz JE, Kvell K.

Front Immunol. 2017 Nov 6;8:1515. doi: 10.3389/fimmu.2017.01515. eCollection 2017.

18.

Retinoid X receptor suppresses a metastasis-promoting transcriptional program in myeloid cells via a ligand-insensitive mechanism.

Kiss M, Czimmerer Z, Nagy G, Bieniasz-Krzywiec P, Ehling M, Pap A, Poliska S, Boto P, Tzerpos P, Horvath A, Kolostyak Z, Daniel B, Szatmari I, Mazzone M, Nagy L.

Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):10725-10730. doi: 10.1073/pnas.1700785114. Epub 2017 Sep 18.

19.

Browning deficiency and low mobilization of fatty acids in gonadal white adipose tissue leads to decreased cold-tolerance of transglutaminase 2 knock-out mice.

Mádi A, Cuaranta-Monroy I, Lénárt K, Pap A, Mezei ZA, Kristóf E, Oláh A, Vámosi G, Bacsó Z, Bai P, Fésüs L.

Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Dec;1862(12):1575-1586. doi: 10.1016/j.bbalip.2017.07.014. Epub 2017 Aug 1.

PMID:
28774822
20.

In situ macrophage phenotypic transition is affected by altered cellular composition prior to acute sterile muscle injury.

Patsalos A, Pap A, Varga T, Trencsenyi G, Contreras GA, Garai I, Papp Z, Dezso B, Pintye E, Nagy L.

J Physiol. 2017 Sep 1;595(17):5815-5842. doi: 10.1113/JP274361. Epub 2017 Aug 8.

21.

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.

Weitz JI, Lensing AWA, Prins MH, Bauersachs R, Beyer-Westendorf J, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Freitas MCS, Holberg G, Kakkar AK, Haskell L, van Bellen B, Pap AF, Berkowitz SD, Verhamme P, Wells PS, Prandoni P; EINSTEIN CHOICE Investigators.

N Engl J Med. 2017 Mar 30;376(13):1211-1222. doi: 10.1056/NEJMoa1700518. Epub 2017 Mar 18.

22.

Prospective, randomised trial of the time dependent antiplatelet effects of 500 mg and 250 mg acetylsalicylic acid i. v. and 300 mg p. o. in ACS (ACUTE).

Zeymer U, Hohlfeld T, Vom Dahl J, Erbel R, Münzel T, Zahn R, Roitenberg A, Breitenstein S, Pap ÁF, Trenk D.

Thromb Haemost. 2017 Feb 28;117(3):625-635. doi: 10.1160/TH16-08-0650. Epub 2017 Jan 19.

PMID:
28102427
23.

Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials.

Beyer-Westendorf J, Lensing AW, Arya R, Bounameaux H, Cohen AT, Wells PS, Middeldorp S, Verhamme P, Hughes R, Kucher N, Pap AF, Trajanovic M, Prins MH, Prandoni P, Weitz JI.

Thromb Res. 2017 Jan;149:29-37. doi: 10.1016/j.thromres.2016.11.014. Epub 2016 Nov 21.

PMID:
27886530
24.

Immunogenic Dendritic Cell Generation from Pluripotent Stem Cells by Ectopic Expression of Runx3.

Takacs E, Boto P, Simo E, Csuth TI, Toth BM, Raveh-Amit H, Pap A, Kovács EG, Kobolak J, Benkö S, Dinnyes A, Szatmari I.

J Immunol. 2017 Jan 1;198(1):239-248. Epub 2016 Nov 16.

25.

Macrophage PPARγ, a Lipid Activated Transcription Factor Controls the Growth Factor GDF3 and Skeletal Muscle Regeneration.

Varga T, Mounier R, Patsalos A, Gogolák P, Peloquin M, Horvath A, Pap A, Daniel B, Nagy G, Pintye E, Póliska S, Cuvellier S, Larbi SB, Sansbury BE, Spite M, Brown CW, Chazaud B, Nagy L.

Immunity. 2016 Nov 15;45(5):1038-1051. doi: 10.1016/j.immuni.2016.10.016. Epub 2016 Nov 8.

26.

Using "spectral families" to assess the reproducibility of glycopeptide enrichment: human serum O-glycosylation revisited.

Pap A, Medzihradszky KF, Darula Z.

Anal Bioanal Chem. 2017 Jan;409(2):539-550. doi: 10.1007/s00216-016-9960-7. Epub 2016 Oct 20.

PMID:
27766363
27.

Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis. A post-hoc analysis.

Cheung YW, Middeldorp S, Prins MH, Pap AF, Lensing AW, Ten Cate-Hoek AJ, Villalta S, Milan M, Beyer-Westendorf J, Verhamme P, Bauersachs RM, Prandoni P; Einstein PTS Investigators Group.

Thromb Haemost. 2016 Sep 27;116(4):733-8. doi: 10.1160/TH16-01-0041. Epub 2016 Sep 1.

PMID:
27583311
28.

Is the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases?

Pap A, Cuaranta-Monroy I, Peloquin M, Nagy L.

Int J Mol Sci. 2016 Jul 30;17(8). pii: E1236. doi: 10.3390/ijms17081236. Review.

29.

Risk of major bleeding in patients with venous thromboembolism treated with rivaroxaban or with heparin and vitamin K antagonists.

Di Nisio M, Ageno W, Rutjes AW, Pap AF, Büller HR.

Thromb Haemost. 2016 Jan;115(2):424-32. doi: 10.1160/TH15-06-0474. Epub 2015 Oct 29.

PMID:
26511068
30.

Erratum: PPARγ activation but not PPARγ haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors.

Kotlinowski J, Grochot-Przeczek A, Taha H, Kozakowska M, Pilecki B, Skrzypek K, Zimoch J, Bartelik A, Derlacz R, Horrevoets AJ, Pap A, Nagy L, Dulak J, Jozkowicz A.

Cardiovasc Diabetol. 2015 May 29;14:65. doi: 10.1186/s12933-015-0205-4. No abstract available.

31.

Treatment of pulmonary embolism with rivaroxaban: outcomes by simplified Pulmonary Embolism Severity Index score from a post hoc analysis of the EINSTEIN PE study.

Fermann GJ, Erkens PM, Prins MH, Wells PS, Pap ÁF, Lensing AW.

Acad Emerg Med. 2015 Mar;22(3):299-307. doi: 10.1111/acem.12615. Epub 2015 Feb 25.

32.

[The message from heroin overdoses].

Pap Á, Hegedűs K.

Orv Hetil. 2015 Mar 1;156(9):352-7. doi: 10.1556/OH.2015.30091. Review. Hungarian.

PMID:
25702255
33.

Use of prestudy heparin did not influence the efficacy and safety of rivaroxaban in patients treated for symptomatic venous thromboem-bolism in the EINSTEIN DVT and EINSTEIN PE studies.

Prandoni P, Prins MH, Cohen AT, Müller K, Pap ÁF, Tewes MC, Lensing AW.

Acad Emerg Med. 2015 Feb;22(2):142-9. doi: 10.1111/acem.12585. Epub 2015 Feb 9.

34.

[Pancreatic cancer. Evidence based management guidelines of the Hungarian Pancreatic Study Group].

Szmola R, Farkas G, Hegyi P, Czakó L, Dubravcsik Z, Hritz I, Kelemen D, Lásztity N, Morvay Z, Oláh A, Párniczky A, Rubovszky G, Sahin-Tóth M, Szentkereszti Z, Szücs Á, Takács T, Tiszlavicz L, Pap Á; Magyar Hasnyálmirigy Munkacsoport, Hungarian Pancreatic Study Group.

Orv Hetil. 2015 Feb 22;156(8):326-39. doi: 10.1556/OH.2015.30063. Review. Hungarian.

PMID:
25662149
35.

[Pediatric pancreatitis. Evidence based management guidelines of the Hungarian Pancreatic Study Group].

Párniczky A, Czakó L, Dubravcsik Z, Farkas G, Hegyi P, Hritz I, Kelemen D, Morvay Z, Oláh A, Pap Á, Sahin-Tóth M, Szabó F, Szentkereszti Z, Szmola R, Takács T, Tiszlavicz L, Veres G, Szücs Á, Lásztity N; Magyar Hasnyálmirigy Munkacsoport, Hungarian Pancreatic Study Group.

Orv Hetil. 2015 Feb 22;156(8):308-25. doi: 10.1556/OH.2015.30062. Review. Hungarian.

PMID:
25662148
36.

[Autoimmune pancreatitis. Evidence based management guidelines of the Hungarian Pancreatic Study Group].

Dubravcsik Z, Farkas G, Hegyi P, Hritz I, Kelemen D, Lásztity N, Morvay Z, Oláh A, Pap Á, Párniczky A, Sahin-Tóth M, Szentkereszti Z, Szmola R, Takács T, Tiszlavicz L, Szücs Á, Czakó L; Magyar Hasnyálmirigy Munkacsoport, Hungarian Pancreatic Study Group.

Orv Hetil. 2015 Feb 22;156(8):292-307. doi: 10.1556/OH.2015.30061. Review. Hungarian.

PMID:
25662147
37.

[Chronic pancreatitis. Evidence based management guidelines of the Hungarian Pancreatic Study Group].

Takács T, Czakó L, Dubravcsik Z, Farkas G, Hegyi P, Hritz I, Kelemen D, Lásztity N, Morvay Z, Oláh A, Pap Á, Párniczky A, Patai Á, Sahin-Tóth M, Szentkereszti Z, Szmola R, Tiszlavicz L, Szücs Á; Magyar Hasnyálmirigy Munkacsoport.

Orv Hetil. 2015 Feb 15;156(7):262-88. doi: 10.1556/OH.2015.30060. Review. Hungarian.

PMID:
25661971
38.

[Acute pancreatitis. Evidence-based practice guidelines, prepared by the Hungarian Pancreatic Study Group].

Hritz I, Czakó L, Dubravcsik Z, Farkas G, Kelemen D, Lásztity N, Morvay Z, Oláh A, Pap Á, Párniczky A, Sahin-Tóth M, Szentkereszti Z, Szmola R, Szücs Á, Takács T, Tiszlavicz L, Hegyi P; Magyar Hasnyálmirigy Munkacsoport, Hungarian Pancreatic Study Group.

Orv Hetil. 2015 Feb 15;156(7):244-61. doi: 10.1556/OH.2015.30059. Review. Hungarian.

PMID:
25661970
39.

PPARγ activation but not PPARγ haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors.

Kotlinowski J, Grochot-Przeczek A, Taha H, Kozakowska M, Pilecki B, Skrzypek K, Bartelik A, Derlacz R, Horrevoets AJ, Pap A, Nagy L, Dulak J, Jozkowicz A.

Cardiovasc Diabetol. 2014 Nov 1;13:150. doi: 10.1186/s12933-014-0150-7. Erratum in: Cardiovasc Diabetol. 2015;14:65.

40.

Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials.

Prins MH, Lensing AW, Brighton TA, Lyons RM, Rehm J, Trajanovic M, Davidson BL, Beyer-Westendorf J, Pap ÁF, Berkowitz SD, Cohen AT, Kovacs MJ, Wells PS, Prandoni P.

Lancet Haematol. 2014 Oct;1(1):e37-46. doi: 10.1016/S2352-3026(14)70018-3. Epub 2014 Sep 28.

PMID:
27030066
41.

Fractal kinetic behavior of plasmin on the surface of fibrin meshwork.

Varjú I, Tenekedjiev K, Keresztes Z, Pap AE, Szabó L, Thelwell C, Longstaff C, Machovich R, Kolev K.

Biochemistry. 2014 Oct 14;53(40):6348-56. doi: 10.1021/bi500661m. Epub 2014 Sep 26.

PMID:
25222106
42.

Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment.

Bauersachs RM, Lensing AW, Prins MH, Kubitza D, Pap ÁF, Decousus H, Beyer-Westendorf J, Prandoni P.

Thromb J. 2014 Nov 24;12:25. doi: 10.1186/1477-9560-12-25. eCollection 2014.

43.

Rivaroxaban for the treatment of symptomatic deep-vein thrombosis and pulmonary embolism in Chinese patients: a subgroup analysis of the EINSTEIN DVT and PE studies.

Wang Y, Wang C, Chen Z, Zhang J, Liu Z, Jin B, Ying K, Liu C, Shao Y, Jing Z, Meng IL, Prins MH, Pap AF, Müller K, Lensing AW; Chinese EINSTEIN Investigators.

Thromb J. 2013 Dec 16;11(1):25. doi: 10.1186/1477-9560-11-25.

44.

Alternatives for the intensive follow-up after curative resection of colorectal cancer. Potential novel biomarkers for the recommendations.

Orosz E, Ember I, Gombos K, Tóth L, Tarpay Á, Pap Á, Ottó S.

Pathol Oncol Res. 2013 Oct;19(4):619-29. doi: 10.1007/s12253-013-9672-7. Epub 2013 Jul 19. Review.

PMID:
23868031
45.

RDH10, RALDH2, and CRABP2 are required components of PPARγ-directed ATRA synthesis and signaling in human dendritic cells.

Gyöngyösi A, Szatmari I, Pap A, Dezso B, Pos Z, Széles L, Varga T, Nagy L.

J Lipid Res. 2013 Sep;54(9):2458-74. doi: 10.1194/jlr.M038984. Epub 2013 Jul 6.

46.

Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension.

Seiler CM, Izbicki J, Varga-Szabó L, Czakó L, Fiók J, Sperti C, Lerch MM, Pezzilli R, Vasileva G, Pap A, Varga M, Friess H.

Aliment Pharmacol Ther. 2013 Apr;37(7):691-702. doi: 10.1111/apt.12236. Epub 2013 Feb 5.

47.

[Need for developing a new strategy in the follow-up of colorectal cancer patients; the micro RNAs (miRNAs), as potential new biomarkers of early detection].

Orosz E, Ember I, Gombos K, Tóth L, Vámosi Nagy I, Tarpay A, Pap A, Ottó S.

Magy Onkol. 2012 May;56(2):93-102. doi: MagyOnkol.2012.56.2.93. Epub 2012 Feb 15. Review. Hungarian.

48.

Effect of enteral feeding on gallbladder function in dogs.

Psáder R, Sterczer A, Pápa K, Harnos A, Szilvási V, Pap A.

Acta Vet Hung. 2012 Jun;60(2):211-22. doi: 10.1556/AVet.2012.018.

PMID:
22609992
49.

Cholagogue-induced gallbladder emptying in the diagnosis of canine biliary obstruction.

Sterczer A, Reiczigel J, Psáder R, Pápa K, Vörös K, Pap A.

Acta Vet Hung. 2012 Jun;60(2):199-209. doi: 10.1556/AVet.2012.017.

PMID:
22609991
50.

[A double immunochemical method for detecting faecal haemoglobin and albumin in rectal screening].

Tarpay A, Szabadosné Németh M, Orosz E, Kásler M, Burai M, Pap A, Ottó S.

Magy Onkol. 2011 Nov;55(4):268-73. doi: MagyOnkol.2011.55.4.268. Epub 2011 Aug 25. Hungarian.

Supplemental Content

Support Center